
Opinion|Videos|May 1, 2025
Episode 6: Updates on Genitourinary Cancer Therapies from ASCO 2025
Panelists discuss how upcoming studies at ASCO 2025 could change practice in kidney, bladder, and prostate cancer, highlighting research on novel drug combinations, biomarkers, organ-sparing approaches, and AI-driven treatment selection.
Advertisement
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on CancerNetwork
1
Frontline Sunvozertinib Improves PFS vs Chemotherapy in EGFR+ NSCLC
2
Considering Venlafaxine as Distress Treatment in Breast Cancer
3
Nogapendekin Alfa/BCG BLA Resubmitted for NMIBC Population
4
The Evolution of Artificial Intelligence in Oncology: Impact on Trials, Workflows, and Outcomes
5
























































